scispace - formally typeset
Open AccessJournal ArticleDOI

NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review.

TLDR
An updated review of the current state of the authors' knowledge about relationship between NF-κB and neuro inflammation is provided to develop a therapeutic approach to neuroinflammation based on a new concept of inflammation as a strategic tool in neuronal cells.
Abstract
The NF-κB (nuclear factor κ-light-chain-enhancer of activated B cells) transcription factor family is a pleiotropic regulator of many cellular signaling pathways, providing a mechanism for the cells in response to a wide variety of stimuli linking to inflammation. The stimulated cells will be regulated by not only the canonical but also non-canonical NF-κB pathways. To initiate both of these pathways, IκB-degradation triggers NF-κB release and the nuclear translocated-heterodimer (or homodimer) can associate with the κB sites of promoter to regulate the gene transcriptions. NF-κB ubiquitously expresses in neurons and the constitutive NF-κB activation is associated with processing of neuronal information. NF-κB can regulate the transcription of genes such as chemokines, cytokines, proinflammatory enzymes, adhesion molecules, proinflammatory transcription factors, and other factors to modulate the neuronal survival. In neuronal insult, NF-κB constitutively active in neuron cell bodies can protect neurons against different injuries and regulate the neuronal inflammatory reactions. Besides neurons, NF-κB transcription factors are abundant in glial cells and cerebral blood vessels and the diverse functions of NF-κB also regulate the inflammatory reaction around the neuronal environment. NF-κB transcription factors are abundant in the brain and exhibit diverse functions. Several central nerve system (CNS) diseases are linked to NF-κB activated by inflammatory mediators. The RelA and c-Rel expression produce opposite effects on neuronal survival. Importantly, c-Rel expression in CNS plays a critical role in anti-apoptosis and reduces the age-related behaviors. Moreover, the different subunits of NF-κB dimer formation can modulate the neuroninflammation, neuronal protection, or neurotoxicity. The diverse functions of NF-κB depend on the subunits of the NF-κB dimer-formation which enable us to develop a therapeutic approach to neuroinflammation based on a new concept of inflammation as a strategic tool in neuronal cells. However, the detail role of NF-κB in neuroinflammation, remains to be clarified. In the present article, we provide an updated review of the current state of our knowledge about relationship between NF-κB and neuroinflammation.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches

TL;DR: The interplay between the NRF2-ARE system and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-ĸB, a protein complex that controls cytokine production and cell survival), has been further investigated in relation to neurodegenerative and neuroinflammatory disorders.
Journal ArticleDOI

Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications

TL;DR: A systematic review of the cellular mediators, i.e., microglia, astroglia and endothelial cells, and the genetic and transcriptional control of inflammation in PD and the immunomodulatory role of dopamine and reactive oxygen species is provided.
Journal ArticleDOI

The Role of Astrocytes in Multiple Sclerosis.

TL;DR: The role of Astrocytes in the formation and evolution of MS lesions is reviewed, including the recently described functional polarization of astrocytes, prototypical pathways forAstrocyte activation are discussed, and mechanisms by which MS treatments affect astroCyte function are summarized.
Journal ArticleDOI

Cellular Specificity of NF-κB Function in the Nervous System.

TL;DR: This review will focus on recent work which is unlocking the pleiotropic roles of NF-κB in neurons and glial cells (including astrocytes and microglia) and the non-cell-autonomous functional impacts of NF -κB activation in the mammalian nervous system.
Journal ArticleDOI

Targeting the Microglial Signaling Pathways: New Insights in the Modulation of Neuropathic Pain.

TL;DR: The objective was to identify new molecular targets that may result in the development of powerful tools to control the signaling associated with neuropathic pain.
References
More filters
Journal ArticleDOI

THE NF-κB AND IκB PROTEINS: New Discoveries and Insights

TL;DR: The transcription factor NF-κB has attracted widespread attention among researchers in many fields based on its unusual and rapid regulation, the wide range of genes that it controls, its central role in immunological processes, the complexity of its subunits, and its apparent involvement in several diseases.
Journal ArticleDOI

Function and activation of NF-kappa B in the immune system.

TL;DR: The inhibition of NF-kappa B activation by antioxidants and specific protease inhibitors may provide a pharmacological basis for interfering with these acute processes in suppressing toxic/septic shock, graft-vs-host reactions, acute inflammatory reactions, severe phase response, and radiation damage.
Journal ArticleDOI

NF-kappaB regulation in the immune system.

TL;DR: The role of NF-κB proteins as potential therapeutic targets in clinical applications and their role in the immune system and inflammatory diseases are discussed.
Journal ArticleDOI

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

TL;DR: Overactivated microglia can be detected using imaging techniques and therefore this knowledge offers an opportunity not only for early diagnosis but, importantly, for the development of targeted anti-inflammatory therapies that might slow or halt the progression of neurodegenerative disease.
Journal ArticleDOI

NF-κB: Ten Years After

TL;DR: The manuscript and the Figures and Table are based on a manuscript originally written by Gordon C. Dickinson in 2012 and then edited by David I. Dickinson and revised by David A. Dickinson.
Related Papers (5)

Neuroinflammation in Alzheimer's disease

Michael T. Heneka, +41 more
- 01 Apr 2015 -